Week_2_Mr._M.docx Critical Thinking Case Study on Mr. M Grand Canyon University: NRS 410 V Critical Thinking Case Study on Mr. M Mr. M is a 70 year-old male who lives in an Assisted Living Facility. He is experienc
...
Week_2_Mr._M.docx Critical Thinking Case Study on Mr. M Grand Canyon University: NRS 410 V Critical Thinking Case Study on Mr. M Mr. M is a 70 year-old male who lives in an Assisted Living Facility. He is experiencing a decline in his mental abilities over the past couple months. This essay is a critical thinking exercise in reviewing the possibility of causative factors, nursing evaluations, and treatments for both him and his family. Although some people might think of dementia first, as his altered mental state and age would suggest, this nurse has seen other diagnoses that have caused similar symptoms and appropriate treatment cleared the altered mentation. A diagnosis of dementia is not correct until others have been ruled out. Clinical Manifestations Mr. M is a 70-year-old male who lives at an assisted living facility (ALF). He carries diagnoses of controlled hypertension, and hypercholesterolemia. Past medical history includes a appendectomy, and surgery to repair a tibial fracture. There were no complications. Mr. M™s medication list is as follows: Lisinopril 20 mg daily for hypertension. This is an ace inhibitor that is controlling his hypertension. Lipitor 40 mg daily is a HMG-CoA reductase inhibitor used to treat hypercholesterolemia. His PRN medications are as follows: Ambien 10 mg PRN is a non-benzodiazepine sedative-hypnotics used to treat his insomnia. There is no mention of how often he uses Ambien, however the PDR recommends geriatric dosage at 5 mg. Xanax 0.5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]